| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 961246 | Journal of Health Economics | 2010 | 8 Pages |
Abstract
ⶠOne highly cited prior research article suggesting newer drugs “pay for themselves” is fundamentally flawed. ⶠSimilar modelling strategies for antihypertensives run counter to established clinical trial evidence. ⶠStudies that do not adequately control for unobserved characteristics that jointly determine drug choice and health expenditures are likely subject to significant bias.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Michael R. Law, Karen A. Grépin,